CVE-2022-30277 describes an insufficient session expiration vulnerability affecting BD Synapsys versions 4.20, 4.20 SR1, and 4.30. This medium-severity vulnerability (CVSS 5.7) could allow an attacker with physical access and low privileges to access, modify, or delete sensitive data, including ePHI, PHI, and PII, with high impact on confidentiality and integrity. There is currently no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
4.20CPE matchmatch criteria | cpe:2.3:a:bd:synapsys:4.20:-:*:*:*:*:*:* | ||
4.20CPE matchmatch criteria | cpe:2.3:a:bd:synapsys:4.20:sr1:*:*:*:*:*:* | ||
4.30CPE matchmatch criteria | cpe:2.3:a:bd:synapsys:4.30:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.0 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.